Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Oct 5, 2010

Premium

Agilent Technologies this week launched its SureSelect Kinome Target Enrichment Kit. The kit enables researchers to focus their next-generation sequencing studies on expressed kinases, the firm said.

Agilent's new assay was developed with Rene Bernards of the Netherlands Cancer Institute and targets genes for greater than 500 known kinases plus a number of cancer genes and untranslated regions. Customers can use Agilent's eArray xD tool to design custom kits.

Agilent said it has created protocols for using its new kit with sequencing instruments sold by Illumina and Life Technologies. Its SureSelect products are generally available in solution for larger studies and on arrays for smaller projects.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.